Thomas Walter

Summary

Affiliation: Hospices Civils de Lyon
Country: France

Publications

  1. doi request reprint Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
    T Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Departement d Oncologie Medicale, 69437 Lyon Cedex 03, France Electronic address
    Lung Cancer 96:68-73. 2016
  2. doi request reprint Endoscopic or percutaneous biliary drainage for Klatskin tumors?
    Thomas Walter
    Division of Medical Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Vasc Interv Radiol 24:113-21. 2013
  3. doi request reprint Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Eur J Cancer 48:1766-73. 2012
  4. doi request reprint Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Lyon, France
    Clin Colorectal Cancer 9:248-54. 2010
  5. doi request reprint Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases
    Thomas Walter
    Hospices Civils de Lyon, Pavillon H, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Eur J Endocrinol 161:639-45. 2009
  6. doi request reprint Well-differentiated endocrine carcinoma of the renal pelvis: report of a case with sustained objective response to octreotide
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Pathol Res Pract 205:183-7. 2009
  7. doi request reprint Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas
    Julien Bollard
    Endocrine Differentiation and Tumorigenesis Laboratory, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 CNRS UMR5286, Universite de Lyon, Faculte Laennec, Lyon, France
    Neuroendocrinology 97:331-40. 2013
  8. doi request reprint Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties
    Thomas Walter
    Lyon Cancer Research Center, Team 4, INSERM UMR1052 CNRS UMR5286, Lyon, France
    Neuroendocrinology 94:200-8. 2011
  9. doi request reprint Angiogenesis and tumor progression in neuroendocrine digestive tumors
    Gilles Poncet
    INSERM, U865, IFR Lyon Est, Universite Claude Bernard Lyon 1, Faculte Laennec, Lyon, France
    J Surg Res 154:68-77. 2009
  10. doi request reprint Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation
    Aymeric Guibal
    Hospices Civils de Lyon, Hopital Edouard Herriot, Service d Imagerie Digestive, 69437 Lyon Cedex 03, France
    Eur Radiol 23:805-15. 2013

Collaborators

Detail Information

Publications51

  1. doi request reprint Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors
    T Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Departement d Oncologie Medicale, 69437 Lyon Cedex 03, France Electronic address
    Lung Cancer 96:68-73. 2016
    ..The aim of this retrospective study was to analyse the efficacy of gemcitabine-oxaliplatin (gemox) or 5-fluorouracil-oxaliplatin (folfox) in the treatment of metastatic pulmonary carcinoid tumors...
  2. doi request reprint Endoscopic or percutaneous biliary drainage for Klatskin tumors?
    Thomas Walter
    Division of Medical Oncology, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada
    J Vasc Interv Radiol 24:113-21. 2013
    ..This study compared outcomes of endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD)...
  3. doi request reprint Is the combination of chromogranin A and pancreatic polypeptide serum determinations of interest in the diagnosis and follow-up of gastro-entero-pancreatic neuroendocrine tumours?
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Eur J Cancer 48:1766-73. 2012
    ..Combining serum CgA and pancreatic polypeptide (PP) levels may increase the sensitivity of tumour markers in the diagnosis of GEPNET...
  4. doi request reprint Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Lyon, France
    Clin Colorectal Cancer 9:248-54. 2010
    ..The aim of this study was to retrospectively analyze the efficacy and safety of the combination of 5-fluorouracil (5-FU), dacarbazine, and epirubicin (FDE) in 39 patients with advanced, well-differentiated neuroendocrine tumors (NETs)...
  5. doi request reprint Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases
    Thomas Walter
    Hospices Civils de Lyon, Pavillon H, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Eur J Endocrinol 161:639-45. 2009
    ..We aimed to gain insight into the functional consequences of ghrelin overproduction in patients with neuroendocrine tumors and its relations with disease characteristics and evolution...
  6. doi request reprint Well-differentiated endocrine carcinoma of the renal pelvis: report of a case with sustained objective response to octreotide
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Pathol Res Pract 205:183-7. 2009
    ....
  7. doi request reprint Antitumor effect of everolimus in preclinical models of high-grade gastroenteropancreatic neuroendocrine carcinomas
    Julien Bollard
    Endocrine Differentiation and Tumorigenesis Laboratory, Centre de Recherche en Cancérologie de Lyon, INSERM U1052 CNRS UMR5286, Universite de Lyon, Faculte Laennec, Lyon, France
    Neuroendocrinology 97:331-40. 2013
    ..Since PDNECs have been shown to strongly express mTOR pathway components, the aim of the present study was to assess the antitumor effect of the mTOR inhibitor everolimus in preclinical models of PDNECs...
  8. doi request reprint Effects of somatostatin and octreotide on the interactions between neoplastic gastroenteropancreatic endocrine cells and endothelial cells: a comparison between in vitro and in vivo properties
    Thomas Walter
    Lyon Cancer Research Center, Team 4, INSERM UMR1052 CNRS UMR5286, Lyon, France
    Neuroendocrinology 94:200-8. 2011
    ..Experimental studies in vitro suggest that somatostatin and some of its analogues used in clinical practice, such as octreotide, may have potent antiangiogenic properties. However, the clinical transposition of these data is difficult...
  9. doi request reprint Angiogenesis and tumor progression in neuroendocrine digestive tumors
    Gilles Poncet
    INSERM, U865, IFR Lyon Est, Universite Claude Bernard Lyon 1, Faculte Laennec, Lyon, France
    J Surg Res 154:68-77. 2009
    ..We used an experimental orthotopic xenograft model to analyze the relations between angiogenic activity and tumor progression in this tumor subset...
  10. doi request reprint Contrast-enhanced ultrasound after devascularisation of neuroendocrine liver metastases: functional and morphological evaluation
    Aymeric Guibal
    Hospices Civils de Lyon, Hopital Edouard Herriot, Service d Imagerie Digestive, 69437 Lyon Cedex 03, France
    Eur Radiol 23:805-15. 2013
    ....
  11. doi request reprint Neuroendocrine tumors of Meckel's diverticulum: lessons from a single institution study of eight cases
    Gilles Poncet
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Lyon, France
    J Gastrointest Surg 15:101-9. 2011
    ..Endocrine tumors of Meckel's diverticulum are rare. Their clinical and pathological characteristics are not well known, making it difficult to assess the best strategy for therapeutic management...
  12. doi request reprint Primary neuroendocrine tumors of the main pancreatic duct: a rare entity
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Lyon, France
    Virchows Arch 458:537-46. 2011
    ..In conclusion, despite their rarity, primary neuroendocrine tumors of the main pancreatic duct deserve recognition and must be considered in the etiological diagnosis of ductal stenosis...
  13. doi request reprint Neuroendocrine neoplasms of the jejunum: a heterogeneous group with distinctive proximal and distal subsets
    Xavier Chopin-Laly
    Service de Chirurgie Digestive, Hospices Civils de Lyon, Hopital Edouard Herriot, 69437, Lyon Cedex 03, France
    Virchows Arch 462:489-99. 2013
    ..Our data suggest that the arbitrary limit between upper and lower jejunal tumors might be fixed at 50 cm from the duodenojejunal ligament...
  14. doi request reprint Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma
    Philippe A Cassier
    Department of Medical Oncology, Hopital Edouard Herriot, Hospices Civils de Lyon, Lyon, France
    Eur J Gastroenterol Hepatol 22:1111-7. 2010
    ..Currently, there is no standard chemotherapy for this disease, but several single agents and combinations have shown promising activity, most notably gemcitabine-based combinations...
  15. doi request reprint Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
    Gilles Boschetti
    Fédération des spécialités digestives, Universite Claude Bernard Lyon 1, Villeurbanne, France
    Eur J Gastroenterol Hepatol 22:1015-8. 2010
    ..Our report shows that another important challenge remains in the identification of predictive factors of response to standard chemotherapy or molecular targeted agents...
  16. doi request reprint Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: biochemical, virological, and histological impact
    Thomas Walter
    Unite de Transplantation Hepatique, Fédération des spécialités digestives, Hopital Edouard Herriot, France
    Liver Transpl 15:54-63. 2009
    ..Our results show the feasibility, safety, and efficacy of long-term antiviral therapy in nonresponder patients with a recurrent posttransplant hepatitis C virus infection...
  17. ncbi request reprint Feasibility and potential benefits of second-line chemotherapy in patients with advanced biliary tract cancer
    Thomas Walter
    Princess Margaret Hospital, Toronto, ON, Canada Princess Margaret Hospital, Toronto, ON, Canada Ontario Cancer Institute, Toronto, ON, Canada Princess Margaret Hospital, Toronto, ON, Canada University Health Network, Toronto General Hospital, Toronto, ON, Canada Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada Princess Margaret Hospital and University of Toronto, Toronto, ON, Canada
    J Clin Oncol 30:338. 2012
    ..338 Background: Chemotherapy is effective in metastatic or unresectable biliary tract cancer (BTC). The benefits of second-line chemotherapy (CT2) are unclear...
  18. doi request reprint Primary malignant solid pseudopapillary tumors of the gastroduodenal area
    Thomas Walter
    Fédération des spécialités digestives, Hospices Civils de Lyon, Hopital Edouard Herriot, Lyon Cedex 03, France
    Clin Res Hepatol Gastroenterol 35:227-33. 2011
    ..In conclusion, we report two unusual cases of extrapancreatic SPT arising in the gastroduodenal area, associated with a malignant course and an extensive metastatic dissemination...
  19. pmc Targeting the PI3K/mTOR pathway in murine endocrine cell lines: in vitro and in vivo effects on tumor cell growth
    Christophe Couderc
    INSERM, U865, Faculte Laennec, Universite Claude Bernard Lyon 1, Lyon, France
    Am J Pathol 178:336-44. 2011
    ..Interestingly, a more potent antitumor efficiency could be obtained by simultaneously targeting several levels of the PI3K/mTOR pathway...
  20. doi request reprint Prediction of response to everolimus in neuroendocrine tumors: evaluation of clinical, biological and histological factors
    Noura Benslama
    Service d Hépatogastroentérologie et d Oncologie Digestive, Hospices Civils de Lyon, Hopital Edouard Herriot, 69437, Lyon Cedex 03, France
    Invest New Drugs 34:654-62. 2016
    ..Prospective studies are required to confirm these results and to assess whether p-p70S6K immunostaining is a prognostic or predictive marker of no-response to everolimus. ..
  21. ncbi request reprint Treatment of metastatic pancreatic neuroendocrine tumors: relevance of ENETS 2016 guidelines
    Margaux Foulfoin
    M Foulfoin, Medical Oncology, Centre Hospitalier Universitaire de Lyon, Lyon, France
    Endocr Relat Cancer . 2016
    ..This retrospective study aimed to determine patient distribution, characteristics and outcome among these 3 groups...
  22. doi request reprint Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound
    Aymeric Guibal
    Service d Imagerie abdominale, Hospices Civils de Lyon, Hopital Edouard Herriot, 69437, Lyon Cedex 03, France
    Eur Radiol 23:1138-49. 2013
    ..To determine the elasticity characteristics of focal liver lesions (FLLs) by shearwave elastography (SWE)...
  23. doi request reprint Gemcitabine and oxaliplatin combination chemotherapy for metastatic well-differentiated neuroendocrine carcinomas: a single-center experience
    Philippe A Cassier
    Multidisciplinary Medical Oncology Day Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
    Cancer 115:3392-9. 2009
    ..The authors assessed the efficacy of gemcitabine-oxaliplatin combination (GEMOX) in the treatment of patients with metastatic neuroendocrine tumors...
  24. ncbi request reprint Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases
    Arnaud Pasquer
    Chirurgie Digestive, Hopital Edouard Herriot, Hospices Civils de Lyon, 69437, Lyon Cedex 03, France
    Ann Surg Oncol 23:804-808. 2016
    ..Our aim was to describe the pattern of involved LN after an extensive LN resection...
  25. ncbi request reprint Endoscopic or percutaneous biliary drainage for Klatskin tumors? A large retrospective study
    Thomas Walter
    Princess Margaret Hospital, Toronto, ON, Canada Department of Medical Imaging, University of Toronto, Toronto General Hospital, Toronto, ON, Canada Toronto General Hospital, Toronto, ON, Canada University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada Ontario Cancer Institute, Toronto, ON, Canada Princess Margaret Hospital, Toronto, ON, Canada Center for Therapeutic Endoscopy and Endoscopic Oncology, St Michael s Hospital, Toronto, ON, Canada
    J Clin Oncol 30:277. 2012
    ..This study compared outcomes of endoscopic biliary drainage (EBD) and percutaneous transhepatic biliary drainage (PTBD)...
  26. doi request reprint A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine
    Cécile Nozières
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Place d Arsonval, Lyon Cedex 03, France
    Eur J Endocrinol 166:1107-11. 2012
    ..This observation points to a possible genotype response to treatment relationships, which could help to design tailor-made treatments in the future...
  27. doi request reprint 18F-FLT and 18F-FDG positron emission tomography for the imaging of advanced well-differentiated gastro-entero-pancreatic endocrine tumours
    Francesco Giammarile
    Nuclear Medicine Department, Hospices Civils de Lyon, Lyon Sud Hospital, France
    Nucl Med Commun 32:91-7. 2011
    ..At present, there are no studies investigating its role in GEP. The aim of this prospective study was to assess the value of 18F-FLT-PET for the evaluation of GEP...
  28. doi request reprint Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up
    Cécile Nozières
    Pavillon EUJOMM, Hospices Civils de Lyon, Hopital Edouard Herriot, Service d Oncologie Medicale, 69437 Lyon Cedex 03, FranceHospices Civils de LyonHôpital Edouard Herriot, Service de Biochimie et Biologie Moléculaire, 69437 Lyon Cedex 03, FranceHôpitaux Universitaires de StrasbourgService de Médecine Interne, endocrinologie et nutrition, Hopital de Hautepierre, Avenue Moliere, 67098 Strasbourg Cedex, FranceHospices Civils de LyonFédération d Endocrinologie du Pôle Est, Aile A1, 59 Boulevard Pinel, 69500 Bron, FranceHospices Civils de LyonHôpital Edouard Herriot, Service Central d Anatomie et Cytologie Pathologiques, 69437 Lyon Cedex 03, FranceHospices Civils de LyonCentre Hospitalier Lyon Sud, Centre de Biologie, 69495 Pierre Benite, FranceINSERMUMR 1052, Lyon Cancer Research Center, Faculte Laennec, 69372 Lyon Cedex 08, FranceUniversité de LyonUniversité Claude Bernard Lyon 1, 69622 Villeurbanne Cedex, France Pavillon EUJOMM, Hospices Civils de Lyon, Hopital Edouard Herriot, Service d Oncologie Medicale, 69437 Lyon Cedex 03, FranceHospices Civils de LyonHôpital Edouard Herriot, University of Southern California
    Eur J Endocrinol 174:335-41. 2016
    ..The aims of this retrospective study were to assess i) the characteristics and prognosis of CT-producing NETs, and ii) the value of CT monitoring during follow-up...
  29. doi request reprint Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis
    Arnaud Pasquer
    Hospices Civils de Lyon, Hopital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France
    Ann Surg Oncol 22:S742-9. 2015
    ..As such, SB-NETs require specific surgical management. This retrospective study examined local recurrence, survival, and prognosis of SB-NETs after adapted surgery...
  30. doi request reprint Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis
    Anne M Horgan
    Princess Margaret Hospital, Toronto, Ontario, Canada
    J Clin Oncol 30:1934-40. 2012
    ..The benefit of adjuvant therapy (AT) for biliary tract cancer (BTC) is unclear, with conflicting results from nonrandomized studies. We report a systematic review and meta-analysis to determine the impact of AT on survival...
  31. doi request reprint Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: long-term results
    Florence Pietu
    Hospices civils de Lyon pavillon H, Hopital Edouard Herriot, Fédération des spécialités digestives, 69437 Lyon Cedex 03, France
    Clin Res Hepatol Gastroenterol 36:146-55. 2012
    ..The objective of this study was to report the long-term tolerability and efficacy of this combination in our ten-year single center experience...
  32. pmc Type 1 serrated polyposis represents a predominantly female disease with a high prevalence of dysplastic serrated adenomas, without germline mutation in MUTYH, APC, and PTEN genes
    Marco Petronio
    Gastroenterology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, France
    United European Gastroenterol J 4:305-13. 2016
    ..The aim of this article is to clarify the epidemiologic, clinical, endoscopic, biological and genetic characteristics of type 1 serrated polyposis patients...
  33. ncbi request reprint Biliary tract cancer: A large institutional experience
    Mairead McNamara
    Princess Margaret Hospital, Toronto, ON, Canada Waterford Regional Hospital, Waterford, Ireland Princess Margaret Hospital, Toronto, ON, Canada Ontario Cancer Institute, Toronto, ON, Canada Princess Margaret Hospital, Toronto, ON, Canada Toronto General Hospital, Toronto, ON, Canada University Health Network and Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada University Health Network, Toronto General Hospital, Toronto, ON, Canada
    J Clin Oncol 30:288. 2012
    ..The aim of this study was to retrospectively review outcomes of pts who presented to a multidisciplinary team at Princess Margaret Hospital, Toronto, with a diagnosis of BTC...
  34. ncbi request reprint Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors
    Rodica Gincul
    Department of Gastroenterology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
    Endoscopy 48:979-986. 2016
    ..Nevertheless, it represents an interesting alternative in small grade 1 duodenal lesions and in patients at high surgical risk...
  35. doi request reprint Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice
    Anne Sophie Dussol
    Department of Digestive Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
    Cancer 121:3428-34. 2015
    ....
  36. doi request reprint Outcome of adjuvant therapy in biliary tract cancers
    Mairéad G McNamara
    Departments of Medical Oncology Palliative Care Medicine Radiation Oncology, Princess Margaret Hospital Departments of Surgery Pathology, Toronto General Hospital, Toronto, ON, Canada Department of Gastroenterology, Edouard Herriot Hospital, Lyon, France Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland
    Am J Clin Oncol 38:382-7. 2015
    ..There are high rates of recurrence after definitive surgery in biliary tract cancer patients. We reviewed the use and effectiveness of adjuvant therapy (AT; chemotherapy±radiotherapy) in a single institution series...
  37. doi request reprint Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease
    Elsa Thimonier
    Hospices Civils de Lyon, Fédération des spécialités digestives, Hopital Edouard Herriot, Lyon, France
    Clin Transplant 28:1339-48. 2014
    ..447 (95%CI 0.257-0.778). Our results strongly suggest that conversion to ERL improves the prognosis of de novo malignancies after LT for alcoholic cirrhosis. Prospective studies are needed to confirm this benefit...
  38. doi request reprint Feasibility and benefits of second-line chemotherapy in advanced biliary tract cancer: a large retrospective study
    Thomas Walter
    Princess Margaret Hospital, Toronto, Ontario, Canada
    Eur J Cancer 49:329-35. 2013
    ..First-line chemotherapy (CT1) is effective in advanced biliary tract cancer (ABTC). The benefits of second-line chemotherapy (CT2) are unclear...
  39. doi request reprint Correlation and agreement between contrast-enhanced ultrasonography and perfusion computed tomography for assessment of liver metastases from endocrine tumors: normalization enhances correlation
    Thibaud Lefort
    Abdominal Imaging Unit, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
    Ultrasound Med Biol 38:953-61. 2012
    ..26 (-0.79; 1.31) for blood volume and +0.21 (-0.46; 0.87) for mean transit time. We conclude that normalization markedly increased correlation between CEUS- and CT-derived perfusion values and allowed agreement assessment...
  40. pmc Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel
    Gilles Poncet
    Department of Digestive Surgery, Edouard Herriot Hospital, 69437 Lyon Cedex 03, France
    World J Gastroenterol 16:1696-706. 2010
    ..Finally, it has to be emphasized that it is of the utmost importance to enroll these patients with a rare disease in prospective clinical trials assessing new therapeutic strategies...
  41. doi request reprint Biopsy specimens obtained with small-caliber endoscopes have comparable diagnostic performances than those obtained with conventional endoscopes: a prospective study on 1335 specimens
    Thomas Walter
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Villeurbanne, France
    J Clin Gastroenterol 44:12-7. 2010
    ..The aim of this study was to evaluate the adequacy of biopsy specimens obtained with small forceps for histologic diagnosis...
  42. pmc Prognostic factors in neuroendocrine carcinoma: biological markers are more useful than histomorphological markers
    Patricia Freis
    Hospices Civils de Lyon, Hopital Edouard Herriot, Service Central d Anatomie et Cytologie Pathologiques, 69437 Lyon Cedex 03, France
    Sci Rep 7:40609. 2017
    ..Considering LDH and AST levels at diagnosis could help physicians to predict survival and to stratify patients for clinical trials...
  43. ncbi request reprint Cardiovascular risk 10 years after liver transplant
    Olivier Guillaud
    Hospices Civils de Lyon, Hopital Edouard Herriot, Fédération des spécialités digestives, Lyon
    Exp Clin Transplant 12:55-61. 2014
    ....
  44. doi request reprint Quality of clinical trials in gastroenteropancreatic neuroendocrine tumours
    Thomas Walter
    Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada
    Neuroendocrinology 96:238-48. 2012
    ..Our aim was to review the quality of treatment trials in NETs in order to inform the design and reporting of future studies...
  45. doi request reprint New treatment strategies in advanced neuroendocrine tumours
    Thomas Walter
    Fédération des spécialités digestives, Hopital Edouard Herriot, Lyon Cedex 03, France
    Dig Liver Dis 44:95-105. 2012
    ..Finally, peptide receptor radionuclide therapy has shown promising activity in non-comparative studies in advanced neuroendocrine tumours...
  46. ncbi request reprint TIPS thrombosis related to abdominal trauma
    Florence Pietu
    Department of Digestive Diseases, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France
    Eur J Gastroenterol Hepatol 22:883-5. 2010
    ..Biological screening identified an inherited protein C deficiency, which supports a recent notion that portal vein thrombosis most often occurs when both the local and the systemic aetiological factors are combined...
  47. doi request reprint Sunitinib achieved fast and sustained control of VIPoma symptoms
    Louis de Mestier
    Department of Hepato Gastroenterology and Digestive OncologyHôpital Robert Debré, Boulevard du général Koenig, 51100 Reims Cedex, FranceDepartment of Gastroenterology and Digestive OncologyHospices Civils de Lyon, Hopital Edouard Herriot, Lyon, France
    Eur J Endocrinol 172:K1-3. 2015
    ..Sunitinib could be a therapeutic option to control refractory VIPoma symptoms in patients with NETs. ..
  48. doi request reprint Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine
    Thomas Walter
    Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada Hospices civils de Lyon, Hopital Edouard Herriot, Oncologie Médicale, Lyon, France
    J Oncol Pharm Pract 20:249-56. 2014
    ..Furthermore, little guidance exists regarding the best methods for monitoring adherence with oral cancer drugs. The purpose of our study was to evaluate adherence to capecitabine using several accepted measures...
  49. doi request reprint Pneumocystis jirovecii pneumonia under everolimus in two patients with metastatic pancreatic neuroendocrine tumors
    Mélodie Carbonnaux
    Department of Gastroenterology and Digestive Oncology, Hospices Civils de Lyon, Hopital Edouard Herriot, Lyon, France
    Invest New Drugs 32:1308-10. 2014
    ..Everolimus, an mTOR inhibitor with immunosuppressive properties, is used in several types of advanced tumors. Materials and..
  50. ncbi request reprint Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center
    Thomas Walter
    Unité de transplantation hépatique Fédération des Spécialités Digestives, Hopital Edouard Herriot, Lyon, France
    Liver Transpl 13:294-301. 2007
    ....
  51. ncbi request reprint The role of angiogenesis in endocrine liver metastases: an experimental study
    Celine Pourreyron
    INSERM, U865, Faculte Laennec, Universite Claude Bernard Lyon 1, Lyon, France
    J Surg Res 144:64-73. 2008
    ..4 +/- 5.6% versus 18.3 +/- 3.4). Our results suggest that active angiogenesis is not necessary for the engraftment and early growth of endocrine cells metastatic to the liver but is required at a later stage of progression...